Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 30/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

43%

3 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

3(42.9%)

Phase 1

1(14.3%)

7Total

Phase 4(3)

N/A(3)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT06770998Not ApplicableRecruiting

A Study of a Novel EEG Neurofeedback System for PTSD Treatment

Role: lead

NCT05040087Not ApplicableActive Not Recruiting

Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)

Role: lead

NCT02624908Phase 4Unknown

Canagliflozin-Mealtime Insulin Rescue

Role: lead

NCT02709018Not ApplicableCompleted

A Controlled Trial of Losartan in Posttraumatic Stress Disorder

Role: collaborator

NCT00214617Phase 4Completed

Effect of Crestor on Lipoprotein Metabolism in Humans

Role: lead

NCT00382928Phase 1Completed

Automatic External Defibrillation Monitoring in Cardiac Arrest

Role: lead

NCT00665678Phase 4Terminated

Neural Correlates of Early Intervention for Posttraumatic Stress Disorder (PTSD)

Role: lead

All 7 trials loaded